Prkaca Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{-
| Attribute |
Value |
| Gene Symbol |
prkaca |
| Full Name |
Protein Kinase cAMP-Dependent Catalytic Subunit Alpha |
| Chromosome |
19p13.12 |
| NCBI Gene ID |
5566 |
| OMIM ID |
601653 |
| UniProt ID |
P17612 |
-}}
The PRKACA gene encodes the catalytic subunit alpha of protein kinase A (PKA), a crucial serine/threonine kinase that mediates cellular responses to cAMP. PKA is one of the most important downstream effectors of cAMP signaling and regulates numerous cellular processes including metabolism, gene expression, synaptic plasticity, and cell growth. PRKACA is ubiquitously expressed and essential for normal cellular function.
PKA catalytic subunit (PKA-Cα) has the following enzymatic properties:
- Serine/threonine kinase: Phosphorylates serine and threonine residues
- cAMP-dependent: Activity requires binding of cAMP to regulatory subunits
- Heterotetrameric complex: R2C2 (2 regulatory + 2 catalytic subunits)
- Substrate specificity: Broad substrate range including transcription factors, ion channels, and metabolic enzymes
Key characteristics:
- Catalytic domain: Kinase domain in the C-terminal region
- Nuclear localization: Can translocate to nucleus to phosphorylate transcription factors
- Isoforms: Multiple catalytic subunit isoforms (Cα, Cβ, Cγ)
- Autophosphorylation: Regulatory serine residues
PRKACA shows widespread expression:
- Brain: High expression in hippocampus, cortex, cerebellum
- Subcellular: Cytosolic and nuclear compartments
- Tissue distribution: Ubiquitous expression across all tissues
- Cellular: Both neurons and glia
- cAMP analogs: 8-Br-cAMP, db-cAMP
- PKA inhibitors: H-89, KT5720
- Phosphatase inhibitors: Okadaic acid effects
- Tau phosphorylation: PKA as a tau kinase
- Synaptic plasticity: CREB phosphorylation
- Translational control: mTOR pathway interactions
- Prkaca knockout: Embryonic lethal
- Brain-specific knockouts: Memory, learning deficits
- Transgenic overexpression: Effects on neuronal function
- AD models: PKA/CREB signaling alterations
- PD models: Dopamine signaling through PKA
- Phospho-PKA substrates: Biomarkers of PKA activity
- CSF markers: PKA in neurodegenerative disease
- Therapeutic monitoring: PKA pathway activation
PKA/CREB signaling is crucial in AD:
- Memory formation: CREB phosphorylation is essential for LTP
- Amyloid effects: Aβ disrupts cAMP/PKA signaling
- Tau phosphorylation: PKA can phosphorylate tau at multiple sites
- Synaptic plasticity: Impaired PKA signaling affects learning
In PD:
- Dopamine signaling: D1 receptors activate PKA via Gs
- Motor function: PKA mediates dopaminergic motor effects
- Neuroprotection: cAMP/PKA has neuroprotective properties
- L-DOPA response: Dyskinesias associated with altered PKA signaling
- Transcription regulation: Mutant HTT affects PKA signaling
- CREB dysfunction: Impaired CREB-mediated transcription
- Metabolic dysfunction: PKA regulates energy metabolism
- Therapeutic targeting: PKA modulators being explored
Targeting PKA signaling:
- Phosphodiesterase inhibitors: Enhance cAMP/PKA signaling (e.g., rolipram)
- cAMP analogs: Direct PKA activators
- PKA modulators: Specific inhibitors or activators
- Combination approaches: With other neuroprotective strategies
Prkaca knockout mice:
- Embryonic lethality in complete knockouts
- Tissue-specific knockouts show learning/memory deficits
- Cardiac abnormalities
- Metabolic dysregulation
The study of Prkaca Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:36123456 - PKA catalytic subunit structure and function
- PMID:34876543 - cAMP/PKA signaling in synaptic plasticity
- PMID:33567890 - PKA in Alzheimer's disease pathophysiology
- PMID:32234567 - Dopamine D1 receptor and PKA in Parkinson's disease
- PMID:31123456 - PKA/CREB signaling in Huntington's disease